E for L Aim Public Co., Ltd. · SET:EFORL
E for L Aim Public — Q3 2016 Earnings Presentation
23 slides from E for L Aim Public's earnings presentation, Dec 14, 2016
Slide 1: 3Q and 9M 2016 Opportunity Day
3Q and 9M 2016 Opportunity Day E FOR L AIM PUBLIC COMPANY LIMITED DECEMBER 14, 2016
Slide 2: Disclaimer
DISCLAIMER This presentation has been prepared by EFORL AIM PUBLIC COMPANY LIMITED (“EFORL”) and is circulated for the purpose of general information only, it is not intended for any specific person or purpose and does not constitute a recommendation regarding the securities of EFORL. No warranty (e
Slide 3: Glossary
GLOSSARY EFORL E for L Aim Public Company Limited SPACEMED Spacemed Co., Ltd. SIAM SNAIL Siam Snail Co., Ltd. THAT’SO That’so Asia Corporation Co., Ltd. WCI Wuttisak Cosmetic Inter Co., Ltd. WCIG Wuttisak Clinic Intergroup Co., Ltd. WCIH WCI Holding Co., Ltd. WGI Wuttisak Grand Inter Co., Ltd. WPI W
Slide 4: Agenda
Highlights Overall performance Performance by Business Financial Status AGENDA Recovery strategies & Operations update 4
Slide 5: Highlights: Financial performance
HIGHLIGHTS Financial performance • Performance in the medical equipment and supplies stabilized. • The performance result for beauty business (especially Wuttisak) declined. • The proceeds from EFORL-W2 mainly to repay debt. 5
Slide 6: Highlights: Operations
HIGHLIGHTS Operations • [EFORL and SPACEMED] Trying to transform some legacy operations to outsourced and smart operations. • [EFORL and SPACEMED] Focus on Quality Assurance with ISO 9001:2015. • [WUTTISAK] Use every strategy to restore Wuttisak. • [WUTTISAK] Boost up Wuttisak brand and focus dire
Slide 7: Agenda
Highlights Overall performance Performance by Business AGENDA Financial Status Recovery strategies & Operations update 7
Slide 8: Overall Performance Q1-Q3 2016
OVERALL PERFORMANCE Unit: MB Q1 - Q3 Y2016 1,000.00 854.64 900.29 864.84 800.00 600.00 Q2 Q3 400.00 Q1 200.00 0.00 (16.40) (32.26) (46.24) (64.94) (70.78) (49.48) (60.47) (200.00) (121.59) (122.36) Total Revenue Earning Before Interest & Tax Net Profit (Net Loss) Portion of the the Company's share
Slide 9: Overall Performance: 9M 2016 vs 2015
Overall performance Unit: MB 1st 9 Months Performance comparing 2016 and 2015 4,000.00 3,393.43 3,000.00 2,599.89 9M_Y2016 9M_Y2015 2,000.00 Portion of the 1,000.00 - Company’s shareholders 23% 476.64 193.30 155.43 COGS 0.00 (147.65) (127.98) - (308.89) (1,000.00) Total Revenue 131% - 260% - EBIT
Slide 10: Agenda
Highlights Overall performance Performance by business Financial Status Recovery strategies & AGENDA Operations update 10
Slide 11: Business: Distributor of Medical Devices and Equipment Q1-Q3 2016
BUSINESS: DISTRIBUTOR OF MEDICAL DEVICES AND EQUIPMENT Q1 - Q3 Y2016 Unit: MB 600.00 Total Revenue Gross Margin 500.00 486.10 465.41 393.19 400.00 300.00 200.00 167.51 177.68 136.39 100.00 0.00 Q1_Y16 Q2_Y16 Q3_Y16 11
Slide 12: Medical Devices Distribution: 9M 2016 vs 2015
BUSINESS: DISTRIBUTOR OF MEDICAL DEVICES AND EQUIPMENT 1ST 9 MONTHS PERFORMANCE Unit: MB COMPARING 2016 AND 2015 1,600.00 1,344.69 1,377.28 1,400.00 9M_Y2016 9M_Y2015 1,200.00 1,000.00 800.00 600.00 -2% 481.58 501.14 400.00 200.00 -4% - Total Revenue Gross Margin 12
Slide 13: Business: Beauty Services
Business: Beauty services Unit: MB Q1 - Q3 Y2016 Total Revenue Gross Margin 500.00 452.56 410.35 390.45 400.00 300.00 200.00 100.00 28.37 0.00 Q1_Y16 (10.90) Q2_Y16 Q3_Y16 (45.62) (100.00) 13
Slide 14: Beauty Services: 9M 2016 vs 2015
Business: Beauty services Unit: MB 1st 9 Months Performance Comparing 2016 and 2015 2,500.00 9M_Y2016 9M_Y2015 2,016.15 2,000.00 1,500.00 1,255.19 - 1,000.00 38% 533.02 500.00 - 105% 0.00 Total Revenue (25.02) Gross Margin (500.00) 14
Slide 15: Agenda
Highlights Overall performance Performance by business Financial Status Recovery strategies & AGENDA Operations update 15
Slide 16: Asset
ASSET Unit: MB 8,000.00 As the End of Q4-15, Q1-16, Q2-16 and Q3-16 7,162.33 7,145.01 7,327.06 7,133.22 7,000.00 6,000.00 5,542.94 5,508.74 5,500.74 5,486.57 5,000.00 4,000.00 3,000.00 2,000.00 1,619.40 1,636.27 1,826.33 1,646.65 1,000.00 - 31-Dec-15 31-Mar-16 30-Jun-16 30-Sep-16 Current Asset Non-C
Slide 17: Liabilities
LIABILITIES Unit: MB As the End of Q4-15, Q1-16, Q2-16 and Q3016 5,000.00 4,697.91 4,500.00 4,164.31 4,207.52 4167.607 4,000.00 3,500.00 3,000.00 2,500.00 2,092.23 2,064.64 2,000.00 1,732.43 1,676.35 1626.072 1646.748 1,605.08 1,421.53 1,500.00 1,000.00 1,053.55 956.92 894.787 467.01 500.00 - 31-Dec
Slide 18: Agenda
Highlights Overall performance Performance by business Agenda Financial Status Recovery strategies & Operations update 18
Slide 19: EFORL AIM & SPACEMED
EFORL AIM & SPACEMED Add new product lines, brand-new target customers with limited budgets and with quality products. Maintain the strength in services and product quality. Transition from legacy systems. Outsourced the labor- intensive and use more information technology. 19
Slide 20: Wuttisak & Siam Snail
Wuttisak & Siam snail o Use every strategy to restore Wuttisak. o Funding, New Product, Sales, Manpower, Cost reduction, asset utilization, etc. o Harvest Advertising investment in Siam snail & invest in advertising medias to boost up Sales volume and its brand. o Increase and extend sales channels.
Slide 21: Beauty Business Recovery Strategies
Beauty Business Recovery Strategies 21 Marketing Strategy PRODUCT: • Revamp Product Catalogue: Skincare, Make up, Body and Supplement COMMUNICATION: • Sustain Wuttisak Brand Awareness Through Wuttisak Cosmetic in Both offline and Online. • Using the Right Spokespersons as a “Spearhead” to 1. Leverag
Slide 22: Product Strategy 2017
PRODUCT STRATEGY 2017 SKINCARE MAKE UP Magik Peptide Face Anti-aging set Anti-aging Moji Cushion Powder foundation Press powder (Mat / Aura) ??? Tone up Whitening ??? Liquid foundation & CC Primer Cream Men Shading Skincare Eye ??? Eyeshadow Palette Mascara Eyeliner Eyebrow Anti-acne Organic Sensiti
Slide 23: Thank you / Questions
ขอบคุณครับ ...คำถำม... 23
E for L Aim Public Company — Q3 2016 Earnings Presentation on 6ix